GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: example 274 [WO2023133472] | IMM-6-415
Compound class:
Synthetic organic
Comment: Envometinib is the INN for a MEK inhibitor. It was included in WHO INN proposed list 133 (10th July 2025). Chemical structure match in patent WO2023133472 [1] suggests that this might be Immuneering Corporation's MEK clinical lead IMM-6-415.
|
|
Bioactivity Comments |
Inhibits downstream ERK phosphorylation in A549 cells by up to 100% (at 10 nM, after 2 hours) [1]. |